24 related articles for article (PubMed ID: 8861660)
1. Impact of Pregnancy and Vitamin A Supplementation on CYP2D6 Activity.
Amaeze OU; Czuba LC; Yadav AS; Fay EE; LaFrance J; Shum S; Moreni SL; Mao J; Huang W; Isoherranen N; Hebert MF
J Clin Pharmacol; 2023 Mar; 63(3):363-372. PubMed ID: 36309846
[TBL] [Abstract][Full Text] [Related]
2. Effect of isotretinoin on CYP2D6 and CYP3A activity in patients with severe acne.
Zhao Y; Vary JC; Yadav AS; Czuba LC; Shum S; LaFrance J; Huang W; Isoherranen N; Hebert MF
Br J Clin Pharmacol; 2024 Mar; 90(3):759-768. PubMed ID: 37864393
[TBL] [Abstract][Full Text] [Related]
3. Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice.
Yang PP; Yeh GC; Huang EY; Law PY; Loh HH; Tao PL
J Biomed Sci; 2015 Sep; 22(1):81. PubMed ID: 26391752
[TBL] [Abstract][Full Text] [Related]
4. Modulation of CYP2D6 and CYP3A4 metabolic activities by Ferula asafetida resin.
Al-Jenoobi FI; Al-Thukair AA; Alam MA; Abbas FA; Al-Mohizea AM; Alkharfy KM; Al-Suwayeh SA
Saudi Pharm J; 2014 Dec; 22(6):564-9. PubMed ID: 25561870
[TBL] [Abstract][Full Text] [Related]
5. Effect of Garden Cress Seeds Powder and Its Alcoholic Extract on the Metabolic Activity of CYP2D6 and CYP3A4.
Al-Jenoobi FI; Al-Thukair AA; Alam MA; Abbas FA; Al-Mohizea AM; Alkharfy KM; Al-Suwayeh SA
Evid Based Complement Alternat Med; 2014; 2014():634592. PubMed ID: 24711855
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen.
ter Heine R; Binkhorst L; de Graan AJ; de Bruijn P; Beijnen JH; Mathijssen RH; Huitema AD
Br J Clin Pharmacol; 2014 Sep; 78(3):572-86. PubMed ID: 24697814
[TBL] [Abstract][Full Text] [Related]
7. Spectrophotometric Determination of Pipazethate HCl and Dextromethorphan HBr using Potassium Permanganate.
Gouda AA; El-Sheikh R; El Shafey Z; Hossny N; El-Azzazy R
Int J Biomed Sci; 2008 Dec; 4(4):294-302. PubMed ID: 23675101
[TBL] [Abstract][Full Text] [Related]
8. Identifying genomic and developmental causes of adverse drug reactions in children.
Becker ML; Leeder JS
Pharmacogenomics; 2010 Nov; 11(11):1591-602. PubMed ID: 21121777
[TBL] [Abstract][Full Text] [Related]
9. The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6.
Nakao M; Muramoto Y; Hisadome M; Yamano N; Shoji M; Fukushima Y; Saruwatari J; Nakagawa K
Eur J Clin Pharmacol; 2007 Apr; 63(4):345-53. PubMed ID: 17297618
[TBL] [Abstract][Full Text] [Related]
10. Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects.
Funck-Brentano C; Boëlle PY; Verstuyft C; Bornert C; Becquemont L; Poirier JM
Eur J Clin Pharmacol; 2005 Dec; 61(11):821-9. PubMed ID: 16315033
[TBL] [Abstract][Full Text] [Related]
11. Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity.
Ducharme J; Abdullah S; Wainer IW
J Chromatogr B Biomed Appl; 1996 Mar; 678(1):113-28. PubMed ID: 8861661
[TBL] [Abstract][Full Text] [Related]
12. A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.
Spanakis M; Vizirianakis IS; Mironidou-Tzouveleki M; Niopas I
Biomed Chromatogr; 2009 Nov; 23(11):1131-7. PubMed ID: 19444798
[TBL] [Abstract][Full Text] [Related]
13. Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.
McCune JS; Lindley C; Decker JL; Williamson KM; Meadowcroft AM; Graff D; Sawyer WT; Blough DK; Pieper JA
J Clin Pharmacol; 2001 Jul; 41(7):723-31. PubMed ID: 11452704
[TBL] [Abstract][Full Text] [Related]
14. Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity.
Jones DR; Gorski JC; Hamman MA; Hall SD
J Chromatogr B Biomed Appl; 1996 Mar; 678(1):105-11. PubMed ID: 8861660
[TBL] [Abstract][Full Text] [Related]
15. A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.
Vengurlekar SS; Heitkamp J; McCush F; Velagaleti PR; Brisson JH; Bramer SL
J Pharm Biomed Anal; 2002 Aug; 30(1):113-24. PubMed ID: 12151071
[TBL] [Abstract][Full Text] [Related]
16. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
